Phenobarbital pre-treatment prevents kainic acid-induced impairments in acquisition learning

Life Sciences

Volumn 67, Issue 6, 2000, Pages 643-650

  Brown Croyts, Laurie M ^a   Caton, Peter W ^a   Radecki, Daniel T ^a   McPherson, Selwyn L ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Kainic acid; Morris water maze; Phenobarbital; Spatial motor learning

Indexed keywords

KAINIC ACID; PHENOBARBITAL; AMINO ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LEARNING DISORDER; LONG TERM POTENTIATION; MAZE TEST; MOTOR PERFORMANCE; NEUROTOXICITY; NONHUMAN; RAT; REACTION TIME; SHORT TERM MEMORY; SPATIAL DISCRIMINATION; TASK PERFORMANCE; ANIMAL; ANIMAL BEHAVIOR; ASSOCIATION; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; LEARNING; LONG EVANS RAT; MALE; MEMORY; SEIZURE;

ANIMALS; BEHAVIOR, ANIMAL; CUES; EXCITATORY AMINO ACID AGONISTS; GABA MODULATORS; KAINIC ACID; LEARNING; MALE; MAZE LEARNING; MEMORY; PHENOBARBITAL; RATS; RATS, LONG-EVANS; SEIZURES;

EID: 0034705494     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00658-5     Document Type: Article

References (33)

1. B. Ault, M. Gruenthal, D. Armstrong, and J.V. Nadler, J. Pharmacol. and Exp. Therap., 239 612-617 (1986).
2. Y. Ben-Ari, Neurosci. 14 375-403 (1985).
3. D.B. Clifford, E.W. Lothman, W.E. Dodson and J.A. Ferrendelli, Expt. Neurol. 76 156-167 (1982)
4. C.B. Dodrill and A.J. Wilensky, Neurol. 40 (suppl 2) 23-27 (1990).
5. S. Feldblum, and R.F Ackermann, Exp. Neurol. 97 255-269 (1987).
6. J. Ferkany, R. Zaczek and J. Coyle, Nature 298 757-759 (1982).
7. A.C. Foster, E.E. Mena, D.T. Monaghan and C.W. Cotman, Nature 289 73-75 (1981)
8. A. Frandsen, B. Quistorff, and A. Schousboe, Neurosci. Lett. 111 233-238 (1990).
9. M.J. Gayoso, C. Primo, A. Al-Majdalawi, J.M. Fernandez, M. Garrosa, and C. Iniguez, Brain Res. 653 92-100 (1994).
10. G. Gordon and G. Grisby, Videomex-V water maze program, Columbus Instruments, Columbus. Ohio (1995).
11. G.E. Handelmann and D.S. Olton, Brain Res. 217 41-58 (1981).
12. J.L. Herranz, J.A. Armijo and R. Arteaga, Epilepsia 29 (6) 794-804, 1988.
13. G.L. Holmes, J.L. Thompson, T.A. Marchi, P.S. Gagriel, M.A. Hogan, F.G. Carl and D.S. Feldman, Ann. Neurol. 27 24-32 (1990).
14. T. Honore, S. Davies, J. Drejer, E. Fletcher, P. Jacobsen, D. Lodge and F. Nielsen, Science 241 701-703 (1988)
15. G.L. Ko, L.M. Brown-Croyts and T. Teyler, Br. Res. Bull. 42(4) 297-302 (1997).
16. G.Y.-P. Lee, L.M. Brown and T.J. Teyler, Brain Res. Bull. 39(1) 39-42 (1996).
17. W. Loscher, B. Nolting and D. Honack, Eur. J. Pharmacol. 152 9-17 (1988).
18. C.M. Macleod, A.S. Dekaban and E. Hunt, Science 202 1102-1104 (1978).
19. K.J. Meador, D.W. Loring and M.E. Nichols, Neurol. 44 (suppl 2), A322 (1994).
20. R.G.M. Morris, J. Neuroscience Methods, 11 47-60 (1984).
21. R.G.M. Morris, E. Anderson, G.S. Lynch and M. Baudry, Nature 319 774-776 (1986).
22. R.G.M. Morris, P. Garraud, J.P.N. Rawlis and J. O'Keefe, Nature (London), 297 681-683 (1982).
23. J.V. Nadler, Life Sci. 29 2031-2042 (1981).
24. J. O'Keefe and J. Dostrovsky, Brain Res. 34 171-175 (1971).
25. D. O'Shaughnessy and G. Gerber, Neurotoxicol.7(3) 187-202 (1986).
26. W. Sieghart, TIPS 13 446-450 (1992)
27. D.B. Smith, S.G. Goldstein and A. Roomet, Epilepsia 27(2) 149-155, 1986.
28. S. Sudha, M.K. Lakshmana and N. Pradhan, Pharmacol. Biochem. and Behav. 54 (3), 633-638 (1996).
29. R.J. Sutherland, I.Q. Wishaw and B. Kolb, Behav. Brain Res., 7 133-153 (1983).
30. T. Sutula, J. Cavazos and G. Golari, J. of Neurosci. 12(11) 4173-4187 (1992).
31. T.P. Sutula, J.E. Cavazos and A. R. Woodward, Hippocampus 4(3) 254-258, 1994.
32. V.I. Teichberg, N. Tal, O. Goldberg and A. Luni, Br. Res. 291 285-292 (1984).
33. C.G. Wasterlain and Y. Shiraska, Brain and Dev. 16 279-95 (1994).